検索条件

閉じる

検索結果 940 件

JaLCDOI 10.18926/AMO/62378
フルテキストURL 75_4_403.pdf
著者 Matoba, Ryo| Morizane, Yuki|
抄録 Epiretinal membrane (ERM) is a common retinal disease characterized by cellular proliferation and metaplasia that lead to the formation of a pathological fibrocellular membrane immediately superjacent to the inner retinal surface. The vast majority of ERMs are considered idiopathic. However, ERM formation can result from various primary intraocular diseases, including retinal breaks and detachment, retinal vascular diseases, and vitreoretinal inflammatory conditions. Although ERMs are generally asymptomatic or cause mild metamorphopsia and/or a modest decrease in visual acuity, some can cause severe macular distortion and macular edema, resulting in significantly impaired function. Surgical removal of ERM is the only treatment, and improvements in vitrectomy systems have enabled less invasive treatment. However, there are currently no standardized criteria for ERM surgery, and the indications for surgery are determined from the patient’s subjective symptoms. Another problem with ERM surgery is that not all patients show satisfactory postoperative recovery of visual function. Thus, further research is needed to determine the criteria for ERM surgery and methods to improve the postoperative prognosis.
キーワード epiretinal membrane vitrectomy optical coherence tomography internal limiting membrane lamellar macular hole
Amo Type Review
出版物タイトル Acta Medica Okayama
発行日 2021-08
75巻
4号
出版者 Okayama University Medical School
開始ページ 403
終了ページ 413
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 英語
著作権者 CopyrightⒸ 2021 by Okayama University Medical School
論文のバージョン publisher
査読 有り
PubMed ID 34511606
Web of Science KeyUT 000697944600001
NAID 120007146059
フルテキストURL fulltext20210824-1.pdf
著者 Tekiki, Nouha| Kuroda, Masahiro| Ishizaka, Hinata| Khasawneh, Abdullah| Barham, Majd| Hamada, Kentaro| Konishi, Kohei| Sugimoto, Kohei| Katsui, Kuniaki| Sugiyama, Soichi| Watanabe, Kenta| Yoshio, Kotaro| Katayama, Norihisa| Ogata, Takeshi| Ihara, Hiroki| Kanazawa, Susumu| Asaumi, Junichi|
キーワード breast cancer field‑in‑field radiotherapy dose reference point acute skin toxicity dose distribution high‑dose area
備考 This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) License.|
発行日 2021-7-21
出版物タイトル Molecular and Clinical Oncology
15巻
3号
出版者 Spandidos Publications
ISSN 2049-9450
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
著作権者 © Tekiki et al.
論文のバージョン publisher
PubMed ID 34349992
DOI 10.3892/mco.2021.2355
Web of Science KeyUT 000680476900001
関連URL isVersionOf https://doi.org/10.3892/mco.2021.2355
フルテキストURL fulltext.pdf
著者 Lin, Wenfeng| Sun, Jingkai| Sadahira, Takuya| Xu, Naijin| Wada, Koichiro| Liu, Chunxiao| Araki, Motoo| Xu, Abai| Watanabe, Masami| Nasu, Yasutomo| Huang, Peng|
キーワード Urothelial bladder cancer doxorubicin cisplatin chemoresistance nitroxoline STAT3
発行日 2021-07-25
出版物タイトル International Journal of Biological Sciences
17巻
12号
出版者 Ivyspring International Publisher
開始ページ 3255
終了ページ 3267
ISSN 1449-2288
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
著作権者 © The author(s).
論文のバージョン publisher
DOI 10.7150/ijbs.63125
Web of Science KeyUT 000682847000007
関連URL isVersionOf https://doi.org/10.7150/ijbs.63125
フルテキストURL fulltext.pdf
著者 Watanabe, Kazunori| Nawachi, Tomoko| Okutani, Ruriko| Ohtsuki, Takashi|
発行日 2021-07-22
出版物タイトル scientific reports
11巻
1号
出版者 Nature Portfolio
開始ページ 14936
ISSN 2045-2322
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
著作権者 © The Author(s) 2021
論文のバージョン publisher
PubMed ID 34294789
DOI 10.1038/s41598-021-94249-7
Web of Science KeyUT 000682800400009
関連URL isVersionOf https://doi.org/10.1038/s41598-021-94249-7
フルテキストURL fulltext.pdf
著者 Tsuchida-Nishiwaki, Mariko| Uchida, Haruhito A.| Takeuchi, Hidemi| Nishiwaki, Noriyuki| Maeshima, Yohei| Saito, Chie| Sugiyama, Hitoshi| Wada, Jun| Narita, Ichiei| Watanabe, Tsuyoshi| Matsuo, Seiichi| Makino, Hirofumi| Hishida, Akira| Yamagata, Kunihiro|
発行日 2021-07-22
出版物タイトル Scientific Reports
11巻
1号
出版者 Nature Portfolio
開始ページ 14990
ISSN 2045-2322
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
著作権者 © The Author(s) 2021
論文のバージョン publisher
PubMed ID 34294784
DOI 10.1038/s41598-021-94467-z
Web of Science KeyUT 000682802200023
関連URL isVersionOf https://doi.org/10.1038/s41598-021-94467-z
フルテキストURL fulltext20210810-3.pdf
著者 Nishii, Kazuya| Ohashi, Kadoaki| Watanabe, Hiromi| Makimoto, Go| Nakasuka, Takamasa| Higo, Hisao| Ninomiya, Kiichiro| Kato, Yuka| Kubo, Toshio| Rai, Kammei| Ichihara, Eiki| Hotta, Katsuyuki| Tabata, Masahiro| Maeda, Yoshinobu| Kiura, Katsuyuki|
キーワード epidermal growth factor receptor osimertinib bevacizumab cetuximab hypoxia‑inducible factor‑1α transforming growth factor‑α
発行日 2021-7-7
出版物タイトル Oncology Letters
22巻
3号
出版者 Spandidos Publications
開始ページ 639
ISSN 1792-1074
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
著作権者 © Nishii et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
論文のバージョン publisher
DOI 10.3892/ol.2021.12900
Web of Science KeyUT 000678494600001
関連URL isVersionOf https://doi.org/10.3892/ol.2021.12900
フルテキストURL fulltext.pdf
著者 Ichihara, Aina| Ojima, Hinako| Gotoh, Kazuyoshi| Matsushita, Osamu| Take, Susumu| Okada, Hiroyuki| Watanabe, Akari| Yokota, Kenji|
キーワード antibody VacA CagA genome
発行日 2021-07-05
出版物タイトル toxins
13巻
7号
出版者 MDPI
開始ページ 467
ISSN 2072-6651
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
著作権者 © 2021 by the authors.
論文のバージョン publisher
DOI 10.3390/toxins13070467
Web of Science KeyUT 000677052200001
関連URL isVersionOf https://doi.org/10.3390/toxins13070467
フルテキストURL fulltext20210721-2.pdf figure20210721-2.pdf
著者 Watari, Shogo| Araki, Motoo| Wada, Koichiro| Yoshinaga, Kasumi| Maruyama, Yuki| Mitsui, Yosuke| Sadahira, Takuya| Kubota, Risa| Nishimura, Shingo| Kobayashi, Yasuyuki| Takeuchi, Hidemi| Tanabe, Katsuyuki| Kitagawa, Masashi| Morinaga, Hiroshi| Kitamura, Shinji| Sugiyama, Hitoshi| Wada, Jun| Watanabe, Masami| Watanabe, Toyohiko| Nasu, Yasutomo|
備考 © 2021 Published by Elsevier Inc. This manuscript version is made available under the CC-BY-NC-ND 4.0 License. http://creativecommons.org/licenses/by-nc-nd/4.0/. This is the accepted manuscript version. The formal published version is available at [https://doi.org/10.1016/j.transproceed.2021.03.043] . |
発行日 2021-4-28
出版物タイトル Transplantation Proceedings
53巻
5号
出版者 Elsevier BV
開始ページ 1494
終了ページ 1500
ISSN 0041-1345
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
論文のバージョン author
PubMed ID 33931247
DOI 10.1016/j.transproceed.2021.03.043
Web of Science KeyUT 000668604400017
関連URL isVersionOf https://doi.org/10.1016/j.transproceed.2021.03.043
フルテキストURL fulltext.pdf
著者 Sugimoto, Manabu| Watanabe, Toshiro| Takaoka, Motoko| Suzuki, Kyoko| Murakami, Tadatoshi| Murakami, Nobutada| Sumikawa, Shoichi|
キーワード fermented plant extract microbiota dextran sulfate sodium inflammatory Clostridiales
発行日 2021-04-06
出版物タイトル Fermentation-Basel
7巻
2号
出版者 MDPI
開始ページ 55
ISSN 2311-5637
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
著作権者 © 2021 by the authors.
論文のバージョン publisher
DOI 10.3390/fermentation7020055
Web of Science KeyUT 000665199500001
関連URL isVersionOf https://doi.org/10.3390/fermentation7020055
フルテキストURL fulltext.pdf
著者 Hatipoglu, Omer Faruk| Uctepe, Eyyup| Opoku, Gabriel| Wake, Hidenori| Ikemura, Kentaro| Ohtsuki, Takashi| Inagaki, Junko| Gunduz, Mehmet| Gunduz, Esra| Watanabe, Shogo| Nishinaka, Takashi| Takahashi, Hideo| Hirohata, Satoshi|
キーワード Pulmonary fibrosis Osteopontin Epithelial-mesenchymal transition
発行日 2021-07
出版物タイトル Biomedicine & Pharmacotherapy
139巻
出版者 Elsevier France-Editions Scientifiques Medicales e
開始ページ 111633
ISSN 0753-3322
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
著作権者 © 2021 The Author(s).
論文のバージョン publisher
DOI 10.1016/j.biopha.2021.111633
Web of Science KeyUT 000663683300007
関連URL isVersionOf https://doi.org/10.1016/j.biopha.2021.111633
フルテキストURL fulltext.pdf
著者 Fukuyasu, Yusuke| Kataoka, Hitomi U.| Honda, Miwako| Iwase, Toshihide| Ogawa, Hiroko| Sato, Masaru| Watanabe, Mayu| Fujii, Chikako| Wada, Jun| DeSantis, Jennifer| Hojat, Mohammadreza| Gonnella, Joseph S.|
キーワード Empathy Humanitude Medical education
発行日 2021-06-04
出版物タイトル BMC Medical Education
21巻
1号
出版者 BMC
開始ページ 316
ISSN 1472-6920
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
著作権者 © The Author(s). 2021
論文のバージョン publisher
PubMed ID 34088308
NAID 120007089818
DOI 10.1186/s12909-021-02773-x
Web of Science KeyUT 000660873600001
関連URL isVersionOf https://doi.org/10.1186/s12909-021-02773-x
JaLCDOI 10.18926/AMO/62237
フルテキストURL 75_3_397.pdf
著者 Sekito, Takanori| Takamoto, Atsushi| Kobayashi, Yasuyuki| Mitsui, Masao| Watari, Shogo| Kubota, Risa| Sadahira, Takuya| Iwata, Takehiro| Nishimura, Shingo| Edamura, Kohei| Sako, Tomoko| Araki, Motoo| Watanabe, Masami| Watanabe, Toyohiko| Shibata, Rei| Ennishi, Daisuke| Nasu, Yasutomo|
抄録 We report a 62-year-old male with metastatic fumarate hydratase-deficient renal cell carcinoma (FH-deficient RCC) without fumarate hydratase (FH) mutation (FH-deficient–like RCC). The International Metastatic RCC Database Consortium risk score was intermediate, and immunotherapy with nivolumab and ipilimumab (Ipi/ Nivo) was initiated. Four cycles of Ipi/Nivo and 5 cycles of nivolumab resulted in a complete response of the metastases. Hypophysitis occurred as an immune-related adverse event after four cycles of Ipi/Nivo. The prognosis of patients with FH-deficient RCC is generally poor. Few reports of FH-deficient RCC successfully treated with Ipi/Nivo have been published. Ipi/Nivo can be effective for treating FH-deficient RCC.
キーワード fumarate hydratase fumarate hydratase-deficient renal cell carcinoma renal cell carcinoma ipilimumab nivolumab
Amo Type Case Report
出版物タイトル Acta Medica Okayama
発行日 2021-06
75巻
3号
出版者 Okayama University Medical School
開始ページ 397
終了ページ 402
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 英語
著作権者 CopyrightⒸ 2021 by Okayama University Medical School
論文のバージョン publisher
査読 有り
PubMed ID 34176946
Web of Science KeyUT 000667147700017
NAID 120007089822
JaLCDOI 10.18926/AMO/62230
フルテキストURL 75_3_351.pdf
著者 Mitamura, Katsuya| Norikane, Takashi| Yamamoto, Yuka| Ihara-Nishishita, Ayumi| Kobata, Takuya| Fujimoto, Kengo| Takami, Yasukage| Kudomi, Nobuyuki| Hoshikawa, Hiroshi| Nishiyama, Yoshihiro|
抄録 We assessed the role of 18F-FDG PET/CT texture indices for the differentiation of squamous cell carcinoma (SCC) and non-Hodgkin’s lymphoma (NHL) in the oropharynx. 18F-FDG PET/CT data for 27 patients with SCC and 25 patients with NHL in the oropharynx were investigated. The maximum standardized uptake value (SUVmax), metabolic tumor volume (MTV), total lesion glycolysis (TLG), and six texture indices (homogeneity, entropy, short-run emphasis, long-run emphasis, low gray-level zone emphasis [LGZE], and high graylevel zone emphasis [HGZE]) were derived from PET images. PET/CT parameters of the SCC patients were compared with those of the NHL patients. The diagnostic accuracy of the indices for differentiating SCC from NHL was calculated by a receiver operating characteristic curve analysis. 18F-FDG uptake in the oropharynx was observed in all of the patients. The SUVmax, MTV, and TLG did not differ significantly between the SCC and NHL groups, but two of the six texture indices (LGZE [p=0.004] and HGZE [p=0.03]) showed significant differences between the groups. LGZE was the best discriminative index for the differentiation of SCC and NHL (55.6% sensitivity, 88.0% specificity). The LGZE and HGZE texture indices derived from 18F-FDG PET/CT images may be useful in differentiating SCC and NHL in the oropharynx.
キーワード 18F-FDG PET/CT oropharyngeal squamous cell carcinoma malignant lymphoma texture
Amo Type Original Article
出版物タイトル Acta Medica Okayama
発行日 2021-06
75巻
3号
出版者 Okayama University Medical School
開始ページ 351
終了ページ 356
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 英語
著作権者 CopyrightⒸ 2021 by Okayama University Medical School
論文のバージョン publisher
査読 有り
PubMed ID 34176939
Web of Science KeyUT 000667147700010
NAID 120007089827
JaLCDOI 10.18926/AMO/62229
フルテキストURL 75_3_345.pdf
著者 Koyama, Kanae| Miura, Noriyoshi| Watanabe, Ryuta| Sawada, Yuichiro| Noda, Terutaka| Nishimura, Kenichi| Asai, Seiji| Fukumoto, Tetsuya| Yanagihara, Yutaka| Miyauchi, Yuki| Kikugawa, Tadahiko| Saika, Takashi|
抄録 The management of blood pressure is a significant concern for surgeons and anesthesiologists performing adrenalectomy for pheochromocytoma. We evaluated clinical factors in pheochromocytoma patients to identify the predictors of postoperative hypotension. The medical records of patients who underwent adrenalectomy for pheochromocytoma between 2001 and 2017 were retrospectively reviewed and clinical and biochemical data were evaluated. Of 29 patients, 13 patients needed catecholamine support in the perisurgical period while 16 patients did not. There were significant differences in median age, tumor size, and blood pressure drop (maxmin) between the 2 groups (68 vs 53 years old, p=0.045; 50 vs 32 mm diameter, p=0.022; 110 vs 71 mmHg, p=0.015 respectively). In univariate logistic analysis, age > 65.5 years, tumor size > 34.5 mm, urine metanephrine > 0.205 mg/day and urine normetanephrine > 0.665 mg/day were significant predictors of prolonged hypotension requiring postoperative catecholamine support. Tumor size and urine metanephrine and urine normetanephrine levels were correlated with postoperative hypotension. These predictors may help in the safe perioperative management of pheochromocytoma patients treated with adrenalectomy.
キーワード urinary metanephrine urinary normetanephrine adrenalectomy pheochromocytoma
Amo Type Original Article
出版物タイトル Acta Medica Okayama
発行日 2021-06
75巻
3号
出版者 Okayama University Medical School
開始ページ 345
終了ページ 349
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 英語
著作権者 CopyrightⒸ 2021 by Okayama University Medical School
論文のバージョン publisher
査読 有り
PubMed ID 34176938
Web of Science KeyUT 000667147700009
NAID 120007089826
JaLCDOI 10.18926/AMO/62226
フルテキストURL 75_3_315.pdf
著者 Wada, Riho| Fujiwara, Masaki| Yamada, Yuto| Nakaya, Naoki| Fujimori, Maiko| So, Ryuhei| Kodama, Masafumi| Higuchi, Yuji| Kakeda, Kyoko| Uchitomi, Yosuke| Yamada, Norihito| Inagaki, Masatoshi|
抄録 It is necessary to assess functional impairment when treating schizophrenia. The World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) has been adopted as a measure of functional disability in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. This study was a secondary analysis from a cross-sectional study of health-related behaviors among patients with schizophrenia. We examined the validity and reliability of the Japanese version of the 12-item WHODAS 2.0 when self-administered by such patients. Participants were 350 outpatients with schizophrenia from a psychiatric hospital. The standard six-factor structure of the WHODAS 2.0 showed a good fit for these participants. The Cronbach’s alpha coefficient was 0.858, showing good internal consistency. The WHODAS 2.0 showed moderate correlations with the modified Global Assessment of Functioning and Kessler 6 scales (r=−0.434 and 0.555, respectively). The results of this study show that the Japanese version of the 12-item self-administered WHODAS 2.0 has good internal consistency and convergent validity among patients with schizophrenia. Further exploration of the usefulness of WHODAS 2.0 in clinical settings is needed.
キーワード disability schizophrenia validity reliability WHODAS 2.0
Amo Type Original Article
出版物タイトル Acta Medica Okayama
発行日 2021-06
75巻
3号
出版者 Okayama University Medical School
開始ページ 315
終了ページ 322
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 英語
著作権者 CopyrightⒸ 2021 by Okayama University Medical School
論文のバージョン publisher
査読 有り
PubMed ID 34176935
NAID 120007089823
JaLCDOI 10.18926/AMO/62225
フルテキストURL 75_3_307.pdf
著者 Ishizaka, Hinata| Kuroda, Masahiro| Tekiki, Nouha| Khasawneh, Abdullah| Barham, Majd| Hamada, Kentaro| Konishi, Kohei| Sugimoto, Kohei| Katsui, Kuniaki| Sugiyama, Soichi| Watanabe, Kenta| Yoshio, Kotaro | Katayama, Norihisa| Ogata, Takeshi| Ihara, Hiroki| Oita, Masataka| Kanazawa, Susumu| Asaumi, Junichi|
抄録 Reports on irradiation dose distribution in breast cancer radiotherapy with sufficient sample size are limited in Asian patients. Elucidating dose distribution in Asian patients is particularly important as their breast volume differs compared to patients in Europe and North America. Here, we examined dose distribution in the irradiation field relative to breast volume for three irradiation methods historically used in our facility. We investigated the influence of breast volume on each irradiation method for Asian women. A total of 573 women with early-stage breast cancer were treated with breast-conserving surgery and adjuvant radiotherapy. Three methods were compared: wedge (W), field-in-field (FIF), and wedge-field-in-field (W-FIF). In patients with small breast volume, FIF decreased low- and high-dose areas within the planning target volume, and increased optimal dose area more than W. In patients with medium and large breast volumes, FIF decreased high-dose area more than W. The absolute values of correlation coefficients of breast volume to low-, optimal-, and high-dose areas and mean dose were significantly lower in FIF than in W. The correlation coefficients of V107% were 0.00 and 0.28 for FIF and W, respectively. FIF is an excellent irradiation method that is less affected by breast volume than W in Asian breast cancer patients.
キーワード breast cancer radiotherapy dose distribution irradiation method breast volume
Amo Type Original Article
出版物タイトル Acta Medica Okayama
発行日 2021-06
75巻
3号
出版者 Okayama University Medical School
開始ページ 307
終了ページ 314
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 英語
著作権者 CopyrightⒸ 2021 by Okayama University Medical School
論文のバージョン publisher
査読 有り
PubMed ID 34176934
Web of Science KeyUT 000667147700006
NAID 120007089838
JaLCDOI 10.18926/AMO/62218
フルテキストURL 75_3_269.pdf
著者 Katsui, Kuniaki| Ogata, Takeshi| Watanabe, Kenta| Yoshio, Kotaro| Kuroda, Masahiro| Hiraki, Takao| Kiura, Katsuyuki| Maeda, Yoshinobu| Toyooka, Shinichi| Kanazawa, Susumu|
抄録 Palliative concurrent chemoradiotherapy (CCRT) is often administered to patients with stage III non-small cell lung cancer (NSCLC). We investigated the clinical outcomes of patients receiving palliative CCRT for NSCLC. Data of patients with NSCLC who underwent palliative CCRT (n=16), preoperative CCRT plus surgery (n=97), or definitive CCRT (n=48) were evaluated. In all groups, the concurrent chemotherapy regimens consisted of cisplatin and docetaxel. Rates of local control (LC), distant metastasis-free survival (DMFS), progression-free survival (PFS), overall survival (OS), and prognosis were compared. The 2-year rates of LC, DMFS, PFS, and OS in 16 patients who underwent palliative CCRT were 44.4%, 12.5%, 12.5%, and 18.8%, respectively. Univariate analysis showed that palliative CCRT was associated with poor LC (p<0.001), DMFS (p<0.001), PFS (p<0.001), and OS (p<0.001) outcomes in patients who completed CCRT as a preoperative treatment and poor LC (p=0.01), DMFS (p=0.003), PFS (p=0.04), and OS (p=0.004) outcomes in patients who were considered for definitive CCRT. Although there were some long-term survivors, the clinical outcomes of palliative CCRT were significantly inferior to those of the ideal treatments. Therefore, careful determination of the appropriate treatment indications and further studies are warranted.
キーワード palliative concurrent chemoradiotherapy cisplatin/docetaxel stage III non-small cell lung cancer
Amo Type Original Article
出版物タイトル Acta Medica Okayama
発行日 2021-06
75巻
3号
出版者 Okayama University Medical School
開始ページ 269
終了ページ 277
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 英語
著作権者 CopyrightⒸ 2021 by Okayama University Medical School
論文のバージョン publisher
査読 有り
PubMed ID 34176930
Web of Science KeyUT 000667147700002
NAID 120007089833
フルテキストURL fulltext.pdf
著者 Yoshinaga, Kasumi| Araki, Motoo| Wada, Koichiro| Sekito, Takanori| Watari, Shogo| Maruyama, Yuki| Mitsui, Yosuke| Sadahira, Takuya| Kubota, Risa| Nishimura, Shingo| Edamura, Kohei| Kobayashi, Yasuyuki| Tanabe, Katsuyuki| Takeuchi, Hidemi| Kitagawa, Masashi| Kitamura, Shinji| Wada, Jun| Watanabe, Masami| Watanabe, Toyohiko| Nasu, Yasutomo|
キーワード diabetes mellitus kidney function kidney transplantation marginal donor
発行日 2021-06-08
出版物タイトル Immunity Inflammation and Disease
出版者 Wiley
ISSN 2050-4527
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
著作権者 © 2021 The Authors.
論文のバージョン publisher
PubMed ID 34102025
NAID 120007053366
DOI 10.1002/iid3.470
Web of Science KeyUT 000658836600001
関連URL isVersionOf https://doi.org/10.1002/iid3.470
フルテキストURL fulltext.pdf
著者 Mise, Koki| Imamura, Mariko| Yamaguchi, Satoshi| Watanabe, Mayu| Higuchi, Chigusa| Katayama, Akihiro| Miyamoto, Satoshi| Uchida, Haruhito A.| Nakatsuka, Atsuko| Eguchi, Jun| Hida, Kazuyuki| Nakato, Tatsuaki| Tone, Atsuhito| Teshigawara, Sanae| Matsuoka, Takashi| Kamei, Shinji| Murakami, Kazutoshi| Shimizu, Ikki| Miyashita, Katsuhiro| Ando, Shinichiro| Nunoue, Tomokazu| Yoshida, Michihiro| Yamada, Masao| Shikata, Kenichi| Wada, Jun|
キーワード cardiovascular event diabetes lectins N-glycans urinary biomarkers
発行日 2021-05-24
出版物タイトル Frontiers In Cardiovascular Medicine
8巻
出版者 Frontiers Media SA
開始ページ 668059
ISSN 2297-055X
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
著作権者 © 2021 by the authors.
論文のバージョン publisher
PubMed ID 34109226
NAID 120007053373
DOI 10.3389/fcvm.2021.668059
Web of Science KeyUT 000658156400001
関連URL isVersionOf https://doi.org/10.3389/fcvm.2021.668059
フルテキストURL fulltext20210608-1.pdf highlights20210608-1.pdf figure20210608-1.pdf table20210608-1.pdf supplement20210608-1.pdf
著者 Kuroda, Shinji| Kikuchi, Satoru| Kakiuchi, Yoshihiko| Watanabe, Megumi| Kuwada, Kazuya| Tsumura, Tomoko| Nishizaki, Masahiko| Kagawa, Shunsuke| Hinotsu, Shiro| Fujiwara, Toshiyoshi|
備考 This is an Accepted Manuscript of an article published by Elsevier BV. © 2021 IJS Publishing Group Ltd. This manuscript version is made available under the CC-BY-NC-ND 4.0 License. http://creativecommons.org/licenses/by-nc-nd/4.0/. This is the accepted manuscript version. The formal published version is available at [https://doi.org/10.1016/j.ijsu.2021.105946] . |
発行日 2021-5
出版物タイトル International Journal of Surgery
89巻
出版者 Elsevier BV
開始ページ 105946
ISSN 1743-9191
NCID AA12063080
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
著作権者 © 2021 IJS Publishing Group Ltd.
論文のバージョン author
PubMed ID 33892160
DOI 10.1016/j.ijsu.2021.105946
Web of Science KeyUT 000651625600016
関連URL isVersionOf https://doi.org/10.1016/j.ijsu.2021.105946